[177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial.
J Nucl Med
; 64(11): 1726-1729, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37709534
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms, Castration-Resistant
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
/
Male
Language:
En
Journal:
J Nucl Med
Year:
2023
Document type:
Article
Affiliation country:
India
Country of publication:
Estados Unidos